Curis
CRIS
#10633
Rank
NZ$22.13 M
Marketcap
NZ$0.57
Share price
55.98%
Change (1 day)
-85.16%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -NZ$56.22 Million

According to Curis's latest financial reports the company's current earnings are NZ$11.65 Million. In 2024 the company made an earning of -NZ$75.68 Million, an increase over its 2023 earnings that were of -NZ$80.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$56.22 Million-25.71%
2024 -NZ$75.68 Million-5.77%
2023 -NZ$80.31 Million-13.1%
2022 -NZ$92.42 Million27.52%
2021 -NZ$72.47 Million65.09%
2020 -NZ$43.9 Million-9.1%
2019 -NZ$48.29 Million-4.73%
2018 -NZ$50.69 Million-41.95%
2017 -NZ$87.31 Million-14.37%
2016 -NZ$0.11 Billion3.55%
2015 -NZ$98.47 Million271.52%
2014 -NZ$26.51 Million76.64%
2013 -NZ$15.01 Million
2011 -NZ$12.75 Million27.76%
2010 -NZ$9.98 Million-43.87%
2009 -NZ$17.78 Million-23.44%
2008 -NZ$23.21 Million56.66%
2007 -NZ$14.82 Million-16.71%
2006 -NZ$17.79 Million-36.92%
2005 -NZ$28.2 Million156.25%
2004 -NZ$11.01 Million-37.24%
2003 -NZ$17.54 Million-93.34%
2002 -NZ$0.27 Billion86.79%
2001 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.73 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.97 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.77 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.51 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$43.81 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.29 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA